Mycophenolate mofetil (CellCept): the newest immunosuppressant.
Explore the source record for details and available documents.
Biomedical subjects
Publications and source records attributed to R L Hoffmann.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Angiotensin-converting enzyme (ACE) inhibitors have been shown to be effective agents that improve the sequelae of left ventricular remodeling following a myocardial infarction. The critical care nurse can play an active role in recognizing those patients who will benefit from ACE inhibitor therapy.
Beta-blockers are effective agents for secondary prevention post-myocardial infarction (MI). They have antiarrhythmic, anti-ischemic, and antihypertensive effects that decrease morbidity and mortality in patients after an MI. Critical care nurses can play an active role in recognizing those patients, especially high-risk individuals, who may benefit from beta-blocker therapy.
Explore the source record for details and available documents.
Within the last decade there has been a multitude of research related to the phenomenon of caregiver burden. Although the concept is relatively new in the literature, the responsibility and ultimately consequences of caring for another family member has existed for centuries. Often this responsibility lies with the female members of the family, but lately more husbands, sons, close family members, or friends have assumed the primary caregiver role. This article reviews the concept of caregiver burden from a historical perspective. Research related to the definition of the concept and its impact on women, men, and siblings and the effect of ethnicity, is discussed.
Recent evidence has shown that homocysteine, a sulfur-containing amino acid, is a risk factor for cardiovascular disease (CVD) and may be one of the missing links in explaining the persistently high mortality associated with CVD. Critical care nurses need to be aware of the pathophysiology, treatment, and research regarding hyperhomocysteinemia and incorporate this knowledge into clinical practice.